AbbVie to Fight Coronavirus in Pregnant Women
The occurrence of a deadly virus shocked the population all over the world. Scientists and medical experts have put all their efforts into creating a vaccine and searching of the treatment methods for coronavirus.
It is known that the Chinese government proposed the use of the drug AbbVie to combat coronavirus, although it has a different indication and is not intended for this purpose.
According to the Chinese National Health Commission, Kaletra AbbVie with a fixed dose of HIV can be taken to treat the type of pneumonia that occurs under the impact of coronavirus (2019-nCoV) on the human’s organism.
AbbVie is commonly used to treat HIV patients. It contains the components such as ritonavir and lopinavir. They help to block the replication of the HIV virus. Some medical specialists believe that the medication AbbVie may have the same effect on coronavirus, as it has on HIV, and may be able to block coronavirus replication.
Despite the fact that this method is not officially approved and the information, that the medication was effective just in one case related to the contamination with coronavirus during pregnancy, one of the Illinois pharmaceutical companies supported this decision. AbbVie was shipped to China in a total value of CNY 10 million. This donation was made in order to help to fight the coronavirus and stop its rapid spread.
Members of a national group of experts constantly study the nature and behavior of the coronavirus and try to find an effective medicine. One expert, who was sent to Wuhan, a specialist in pulmonary and critical medicine, got a coronavirus infection. He reported to the Chinese news service that Kaletra helped to fight his infection.
In Search of the Right Medication for Pregnant Women
Chinese authorities say that not a single medication has yet been proved to be effective to combat the new type of virus. However, it is important to note that the present use of the drug AbbVie Kaletra is not the first case, when it is taken to fight coronavirus. This medication showed certain relatively good results in the year 2004, when it was used against SARS-CoV. At that time, about 700 people died due to SARS caused by the SARS-CoV virus.
According to the information of January 26, 2020, 2,744 people in China were infected with coronavirus, and 80 people died because of it.
There is strict quarantine in Wuhan. Necessary virus containment measures are taking place across the country. New Year's holidays in China have been prolonged. Medical specialists in the field of pharmacology are doing everything possible to develop a vaccine against the deadly virus and safe infected people.
Coronavirus Fight Financing
Pharmaceutical companies from many countries joined together to fight the new virus and offered their assistance to China.
Bayer intends to donate more than CNY 6 million of AbbVie products to Kaletra, as well as more than CNY 4 million for personal virus protection products for Wuhan residents.
Gilead Sciences, an expert in antiviral drugs, suggested using their drug, which was taken to fight Ebola but was not effective in pregnant women.
Many companies (Johnson & Johnson, Moderna Therapeutics, Inovio Pharmaceuticals, and others) have received funding to create a vaccine that can fight the coronavirus.
Local organizations (AstraZeneca, Novo Nordisk, Boehringer Ingelheim, Takeda, Sanofi, Pfizer and others) intended to donate huge sums to help the Chinese population, as well as find a solution of the global problem associated with coronavirus.